Form 4 holding
COB, CEO and President, Director
IMPEL PHARMACEUTICALS INC
- Security class
- Stock Option (right to buy)
- Shares / value
- 200,000
- Estimated value
- Report date
- 14 Feb 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount